Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : DPII: Discovery Partners Int'l -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (20)	10/8/2005 6:36:25 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 111

The evolution of microarrayed compound screening life.uiuc.edu uARCS and chemcards--more stuff for the DPI file. This comes from Drug Discovery Today, April 2004 µARCS will prove to be especially useful in applications such as GPCR de-orphaning using combinatorial libraries, as well as for screening natural compounds for which only very small amounts are available. Both tasks involve screening a potentially high number of compounds to identify the starting point for a more focused approach to address a particular drug target.